Brief: Shanghai Henlius Biotech Logs H1 Net Income RMB 390.1 Mln
25/08/2025 11:32
Aug 25 (Reuters) - Shanghai Henlius Biotech Inc 2696.HK: H1 NET INCOME RMB 390.1 MILLION H1 REVENUE RMB 2,819.5 MILLION H1 GROSS PROFIT RMB 2,199.2 MILLION Further company coverage: 2696.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Henlius Biotech
See all newsBrief: Shanghai Henlius Biotech Says Wenjie Zhang Resigns As Chairman
Brief: Shanghai Henlius Biotech Enters Collaboration And License Agreement With Amberstone Biosciences
Brief: Shanghai Henlius Biotech Says NDA For 120 Mg Biosimilar Denosumab HLX14 Accepted By NMPA
China's Henlius H1 revenue jumps on drug sales, license income
Brief: Shanghai Henlius Biotech Logs HY Profit RMB 430.4 Mln